Financials in USD. Standardized financial statements.
A compact view of how Zepp Health Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.82B | $1.33B | $2.50B | $4.22B | $6.17B | $6.08B | $5.80B | $3.79B | $2.00B | $1.63B |
| Revenue Growth? | +36.1% | -46.6% | -40.8% | -31.7% | +1.4% | +4.9% | +53.0% | +89.6% | +22.7% | 0.0% |
| Cost of Revenue? | $1.10B | $820.57M | $1.84B | $3.40B | $4.88B | $4.82B | $4.33B | $2.81B | $1.52B | $1.34B |
| Gross Profit? | $711.63M | $512.88M | $653.70M | $817.22M | $1.29B | $1.26B | $1.46B | $976.09M | $482.26M | $288.86M |
| Gross Margin? | +39.2% | +38.5% | +26.2% | +19.4% | +20.9% | +20.7% | +25.3% | +25.8% | +24.1% | +17.7% |
| Operating Expenses? | $916.56M | $857.92M | $869.22M | $1.23B | $1.20B | $1.10B | $844.74M | $596.10M | $304.87M | $274.86M |
| Operating Income? | -$204.93M | -$345.04M | -$215.52M | -$417.45M | $92.73M | $164.69M | $619.04M | $379.99M | $177.39M | $14.00M |
| EBITDA? | -$204.93M | -$345.66M | -$142.88M | -$261.43M | $200.80M | $276.76M | $667.78M | $408.15M | $190.70M | $32.70M |
| Income Before Tax | -$263.13M | -$453.59M | -$237.22M | -$361.11M | $145.78M | $246.62M | $649.50M | $403.50M | $189.81M | $28.28M |
| Income Tax Expense | $17.79M | $99.99M | -$17.20M | -$67.03M | $10.61M | $29.45M | $77.68M | $54.07M | $26.92M | $3.23M |
| Net Income? | -$280.92M | -$554.13M | -$220.49M | -$293.37M | $136.02M | $216.27M | $573.64M | $353.31M | $163.46M | $25.05M |
| EPS? | $-283.04 | $-34.16 | $-1.96 | $-2.71 | $1.38 | $2.25 | $37.61 | $8.57 | $0.68 | $-3.49 |
| Diluted EPS? | $-283.04 | $-34.16 | $-1.96 | $-2.71 | $1.31 | $2.16 | $35.84 | $8.12 | $0.65 | $-3.52 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality